QM/MM Simulations Reveal Differences in Hydrolysis Mechanisms of Ertapenem and Faropenem in L1 Metallo-β-Lactamase Leading to Different Product Binding Modes
Year: 2026
Type: preprint
Abstract: L1, a class B3 metallo-β-lactamase (MBL) from Stenotrophomonas maltophilia, efficiently hydrolyzes most β-lactam antibiotics and evades β-lactamase inhibitors, both clinically available and those in late-stage trials targeting other MBLs. Detailed understanding of the L1 mechanism is necessary to design effective inhibitors. Building on our previous quantum mechanics/molecular mechanics (QM/MM) study of L1catalyzed hydrolysis of the penem antibiotic faropenem, we here investigate hydrolysis of a 1β-methyl carbapenem (ertapenem) using MM and enhanced sampling QM/MM MD simulations at the DFTB3 level, comparing the two mechanisms to understand the distinct product binding modes observed crystallographically. The geometry of the transition state for the first, amide bond cleavage, reaction step is similar for both substrates. However, differences are apparent in the subsequent proton transfer step, corresponding to the different binding modes observed crystallographically for the respective products. For faropenem, a bulk water molecule enters the active site, yielding the (2S )-imine-∆1 product via rotation about the C5–C6 bond and protonation at position C2. For ertapenem, the metal-bridging hydroxide is the proton source, and the equivalent rotation is associated with a relatively high barrier. Instead, the more favorable rotation of the C6-carboxyl enables protonation at C2, yielding the (2S )-imine-∆1 product in a distinct binding mode. Long-timescale MM MD simulations indicate rapid dissociation of the ertapenem-derived imine, compared to the faropenem-derived species, from the L1 active site, offering insight into the relative stability of these binding modes. These data reveal how carbapenem and MBL structure influence hydrolysis pathways, and may inform rational MBL inhibitor design.
Source: ChemRxiv
Institution: University of Bristol
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: University of Bristol
OpenAlex ID: W7236611093
